Search Results 891-900 of 17378 for alopecia

1. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

   All acute toxic effects of any prior antitumor therapy resolved to Grade ≤1 before the start of study therapy (with the exception of alopecia [Grade 1 or 2 ...

2. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

   Has unresolved toxicities from previous anticancer therapy, defined as toxicities (other than alopecia) not yet resolved to NCI-CTCAE V5.0, Grade ≤ 1 or ...

3. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

   ... alopecia, vitiligo). Participants with Grade 2 toxicities that are deemed stable or irreversible (e.g., chemotherapy related arthritis or tendinitis, skin ...

4. Allergic Diseases - Clinical trials

   Find open clinical trials in the Mayo Clinic Division of Allergic Diseases.

5. A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies - Mayo Clinic

   Grade 2 neuropathy or alopecia;; For the monotherapy cohorts: Grade 2 immune-related endocrinopathy attributed to a checkpoint inhibitor and controlled with ...

6. Choose Mayo Clinic

   Dr. Brown: We can bring colleagues from many different areas of medicine, expertise across virtually any field. Lily Wong-Kisiel, M.D., Pediatric Neurology, ...

7. A Study of SAR442085 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... alopecia). Participant has congestive heart failure (New York Heart Association) Grade ≥ II; cardiac myopathy, active ischemia, or any other uncontrolled ...

8. A Study of Cediranib and Olaparib Combined, Compared to Either Drug Alone, or to a Standard Chemotherapy in Treating Patients who have a Return of Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   Toxicities of prior therapy (excepting alopecia) should be resolved to less than or equal to grade 1 as per CTCAE v 4.0; Adequately controlled blood pressure ...

9. Weight-loss basics

   Need to lose weight? Skip the fad diets. Go for healthy eating and exercise habits. It's the smart way to take weight off and keep it off.

10. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

    Recovery to Grade 1 of any clinically significant toxicity (excluding alopecia and peripheral neuropathy) prior to initiation of study drug administration.